Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,192 | 211 | 99.6% |
| Education | $13.89 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $433.11 | 29 | $0 (2020) |
| AbbVie Inc. | $429.79 | 28 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $382.07 | 24 | $0 (2020) |
| PFIZER INC. | $326.85 | 29 | $0 (2020) |
| GlaxoSmithKline, LLC. | $280.78 | 14 | $0 (2019) |
| Allergan, Inc. | $230.71 | 7 | $0 (2020) |
| Amgen Inc. | $193.98 | 10 | $0 (2019) |
| Astellas Pharma US Inc | $169.03 | 10 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $116.85 | 21 | $0 (2020) |
| Shire North American Group Inc | $106.52 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $26.69 | 1 | AbbVie Inc. ($26.69) |
| 2020 | $286.71 | 15 | Allergan, Inc. ($102.28) |
| 2019 | $828.21 | 56 | AbbVie, Inc. ($129.95) |
| 2018 | $1,129 | 64 | Boehringer Ingelheim Pharmaceuticals, Inc. ($179.80) |
| 2017 | $935.59 | 76 | GlaxoSmithKline, LLC. ($182.28) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Central Nervous System | ||||||
| 03/03/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Anemia | ||||||
| 02/27/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: VACCINE | ||||||
| 02/26/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: RESPIRATORY | ||||||
| 02/11/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Anemia | ||||||
| 02/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular | ||||||
| 01/30/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: VACCINES | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/07/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Respiratory | ||||||
| 01/06/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Cardiovascular | ||||||
| 12/11/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/09/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/05/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Central Nervous System | ||||||
| 12/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: VACCINES | ||||||
| 11/15/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: ANTIBIOTICS | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 28 | 32 | $3,360 | $617.10 |
| 2020 | 5 | 441 | 579 | $73,730 | $31,937 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 16 | $1,920 | $381.80 | 19.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 16 | $1,440 | $235.30 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 170 | $32,300 | $11,968 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 136 | 214 | $24,870 | $9,777 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 81 | 81 | $12,960 | $9,746 | 75.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 42 | 42 | $2,520 | $285.28 | 11.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 68 | 72 | $1,080 | $159.95 | 14.8% |
About Dr. Rocco Andreozzi, DO
Dr. Rocco Andreozzi, DO is a Family Medicine healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386608164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rocco Andreozzi, DO has received a total of $3,206 in payments from pharmaceutical and medical device companies, with $26.69 received in 2021. These payments were reported across 212 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,192).
As a Medicare-enrolled provider, Andreozzi has provided services to 469 Medicare beneficiaries, totaling 611 services with total Medicare billing of $32,554. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Westerly, RI
- Active Since 04/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386608164
Products in Payments
- STIOLTO RESPIMAT (Drug) $305.29
- Creon (Drug) $280.05
- CHANTIX (Drug) $219.58
- FARXIGA (Drug) $185.95
- MYRBETRIQ (Drug) $131.68
- UBRELVY (Drug) $128.97
- LINZESS (Drug) $128.43
- Synthroid (Drug) $123.05
- Aimovig (Biological) $108.33
- INCRUSE (Drug) $99.64
- BEVESPI AEROSPHERE (Drug) $85.71
- Vascepa (Drug) $84.28
- STIOLTO (Drug) $82.22
- VYVANSE (Drug) $78.16
- FASENRA (Drug) $75.41
- Baxdela (Drug) $67.47
- Prolia (Biological) $66.74
- PRALUENT ALIROCUMAB INJECTION (Biological) $63.07
- INJECTAFER (Drug) $61.02
- PREVNAR - 13 (Biological) $60.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Westerly
Bartel Crisafi, Md, MD
Family Medicine — Payments: $3,374
Joseph Giancaspro, Md, MD
Family Medicine — Payments: $3,047
Mr. Walter Curtice, M.d, M.D
Family Medicine — Payments: $1,762
Ms. Marianne Longacre, Do, DO
Family Medicine — Payments: $367.41
Peter Willis, M.d, M.D
Family Medicine
Dr. Bernard Marzilli, Jr., D.o, D.O
Family Medicine